AR124188A1 - Antígenos nuevos - Google Patents
Antígenos nuevosInfo
- Publication number
- AR124188A1 AR124188A1 ARP210103313A ARP210103313A AR124188A1 AR 124188 A1 AR124188 A1 AR 124188A1 AR P210103313 A ARP210103313 A AR P210103313A AR P210103313 A ARP210103313 A AR P210103313A AR 124188 A1 AR124188 A1 AR 124188A1
- Authority
- AR
- Argentina
- Prior art keywords
- fimh
- amino acid
- acid sequence
- fragment
- fusion
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 239000012634 fragment Substances 0.000 abstract 3
- 230000004927 fusion Effects 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 208000019206 urinary tract infection Diseases 0.000 abstract 2
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención está dirigida a polipéptidos FimH modificados nuevos, ácidos nucleicos que los codifican y el uso de polipéptidos y ácidos nucleicos en el tratamiento y/o la prevención de enfermedades, en particular, las infecciones del tracto urinario (UTI). Reivindicación 1: Un péptido que tiene una secuencia de aminoácidos que comprende o consiste en lo siguiente: (a) FimH; o una variante, fragmento y/o fusión de FimH y (b) una secuencia de aminoácido que complementa la cadena donante, caracterizado porque (b) está secuencia abajo de (a). Reivindicación 2: Un polipéptido que comprende o consiste en una secuencia de aminoácidos X-(a)-L-(b)-Y, caracterizado porque (a) es un polipéptido FimH; o una variante, fragmento y/o fusión de FimH; L es un primer conector; (b) es una secuencia de aminoácidos complementaria de la cadena donante, X es una secuencia opcional N-terminal; Y es una secuencia opcional C-terminal, donde Y no se deriva de FimC o FimH o un fragmento de estos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20211337 | 2020-12-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR124188A1 true AR124188A1 (es) | 2023-02-22 |
Family
ID=73694911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210103313A AR124188A1 (es) | 2020-12-02 | 2021-11-30 | Antígenos nuevos |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR124188A1 (es) |
-
2021
- 2021-11-30 AR ARP210103313A patent/AR124188A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR108442A1 (es) | Proteínas de fusión gdf15 y usos de estas | |
| León-Calvijo et al. | Antibacterial activity of synthetic peptides derived from lactoferricin against Escherichia coli ATCC 25922 and Enterococcus faecalis ATCC 29212 | |
| AR114339A1 (es) | Plataforma de presentación, productos y métodos con endosporas basadas en paenibacillus | |
| AR044776A1 (es) | Proteinas de fusion analogas glp-1 | |
| NO20063026L (no) | Antistoffer | |
| MX9606536A (es) | Proteinas n-terminalmente extendidas expresadas en levaduras. | |
| ES2191674T3 (es) | Adrenomedulina. | |
| BRPI0606612A2 (pt) | expressão recombinante de proteìnas em uma forma de duas cadeias ligadas por dissulfeto | |
| ES8802394A1 (es) | Un procedimiento para preparar una proteina de fusion derivada de la secuencia de aminoacidos de la preprorrelaxina humana. | |
| DK0532587T3 (da) | Fremgangsmåder til trans-destabilisering af specifikke proteiner in vivo | |
| CO2021017664A2 (es) | Péptidos | |
| EP1548107A4 (en) | CHROMOPROTEIN AND FLUORO PROTEINS | |
| IL277838B1 (en) | Method for cleavage of solid phase-bound peptides from the solid phase | |
| PE20020857A1 (es) | Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras | |
| ATE280827T1 (de) | Penaeidine: antimikrobielle peptide aus krebstieren | |
| PE20020875A1 (es) | Peptidos supersegregables en procedimientos para su produccion y para la mejora en paralelo de las formas exportadas de uno o mas de otros peptidos de interes | |
| MX2023014118A (es) | Proteina de fusion de anticuerpo con dominio del ligando de nkg2d. | |
| AR124188A1 (es) | Antígenos nuevos | |
| BG101226A (bg) | Метод за производство на модифициран инхибитор палидипин на колагениндуцирано тромбоцитно натрупване | |
| Nozu et al. | Amino Acid Sequences of Some Common Japaense Stratins of Tobacco Mosaic Virus | |
| DK0794255T3 (da) | Fremgangsmåde til spaltning af kimært protein ved anvendelse af processeringsenzym | |
| Olafson et al. | Amino terminal sequence homology among variant surface glycoproteins of African trypanosomes | |
| ES2072422T3 (es) | Procedimiento para la produccion de peptidos amidados en alfa en el terminal c. | |
| WO2024030977A3 (en) | Novel melanocortin analogs | |
| AR012744A1 (es) | Molecula de acido nucleico que codifica una proteina vinculadora de sucrosa, proteina vinculadora de sucrosa y metodo para producir una proteinavinculadora de sucrosa. |